Post date March 29, 2024 Experience Doma take-private acquisition by Title Resources Group We are advising Doma on the transaction
Post date February 12, 2024 Experience Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics We are advising Gilead Sciences on the acquisition
Post date November 28, 2023 Experience Uber $1.725 billion convertible notes offering and capped call transactions The 0.875% convertible senior notes are due 2028
Post date September 18, 2023 Experience Intuit $4 billion notes offering The investment-grade offering comprises four tranches of notes
Post date May 18, 2023 Experience Texas Instruments $1.6 billion notes offering We advised Texas Instruments on its investment-grade debt offering
Post date May 5, 2023 Experience DexCom $1.25 billion convertible notes offering and capped call transactions The 0.375% convertible senior notes are due 2028
Post date December 7, 2022 Experience Flex $400 million notes offering The investment-grade notes are due 2028
Post date November 14, 2022 Experience Snail $15 million IPO We advised Snail on its IPO and Nasdaq listing
Post date November 9, 2022 Experience Lucid $600 million at-the-market offering and $915 million additional investment The common stock is listed on Nasdaq
Post date September 20, 2022 Experience CrowdStrike Holdings acquisition of Reposify We are advising CrowdStrike on the transaction